58 Views | 26 Downloads
Paula Mc Kenna, Janssen Global Public Health, Disease Management Programs, Janssen Pharmaceutica Nv, Turnhoutseweg 30, Beerse B-2340, Belgium. Email: pmckenna@its.jnj.com
Romain Rutten, Serge Masyn, Annik Willems, Anne De Paepe, Paula Mc Kenna contributed to the conception, design & implementation of the campaign. Jean Baptiste Mazarati, Felix Sayinzoga, Etienne Karita, Jean Nepo Nduwamungu, Julien Nyombayire, Rosine Ingabire, Amelia Mazzei, Monica Amponsah and Seth Gogo Egoeh supported implementation of the campaign and were responsible for acquisition of the data. Romain Rutten, Serge Masyn, Annik Willems, Anne De Paepe, Paula Mc Kenna, Monica Amponsah, Seth Gogo Egoeh and Nnamdi Ezeanochie contributed to the analysis and interpretation of data. All authors contributed to drafting the manuscript. All authors read and approved the final manuscript.
We thank the participants, community health-care workers and support staff for their participation and efforts during the campaign and also the Ministry of Health of Rwanda. We are also very grateful to the Rinda Ubuzima organization for their work around community engagement for this campaign. We are thankful to Johnson and Johnson Health and Wellness Solutions team for their behavioral science work around mobile messaging.
Romain Rutten, Serge Masyn, Annik Willems, Anne De Paepe, Paula Mc Kenna and Nnamdi Ezeanochie are Janssen employees and may be stock owners of Johnson and Johnson. Jean Baptiste Mazarati, Felix Sayingoza, Etienne Karita, Jean Nepo Nduwamungu, Rosine Ingabire, Amelia Mazzei, Monica Amponsah and Seth Gogo Egoeh have no conflicts of interest to declare.
No potential conflicts of interest were disclosed.
This campaign was supported by the Government of Rwanda, the UK Foreign, Commonwealth and Development Office, Wellcome [Grant number 220214/Z/20/Z] and Johnson & Johnson Global Public Health. Writing support was provided by Patrick Hoggard of Zoetic Science, an Ashfield company, part of UDG Healthcare plc, and was funded by Johnson & Johnson Global Public Health. EBODAC support offered to this vaccine campaign has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement EBODAC (grant nr. 115847). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
© 2021 The Author(s). Published with license by Taylor & Francis Group, LLC.